Evidence map›Paper›PMID 41381364›Full record

ArticleGenes & development2026

Transcriptional derepression of negative regulators of MAP kinase supports maintenance of diapause ES cells in the pluripotent state.

Tuo Zhang, Ryan J Marina, Rab Prinjha, Karen Adelman, Alexander Tarakhovsky

Abstract read
In one paragraph

Article in Genes & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tuo Zhang *Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, New York 10065, USA.
Ryan J Marina *Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Rab PrinjhaGlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom.
Karen AdelmanDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Alexander TarakhovskyLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, New York 10065, USA; tarakho@rockefeller.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutrient deficiency during pregnancy in many animal species can induce embryonic diapause, a state characterized by systemic changes in biosynthetic processes that minimize reliance on external energy sources while ensuring survival. Remarkably, these changes do not affect the pluripotent state of embryonic stem (ES) cells, allowing normal development once diapause ends. Here we identify a transcriptional mechanism that maintains ES cell pluripotency during diapause. We show that inhibition of mTOR, which induces a diapause-like state in ES cells, rapidly upregulates genes encoding negative regulators of the MAP kinase (NRMAPK) pathway, a key driver of ES cell differentiation. Elevated NRMAPK expression and associated suppression of MAP kinase activity are also hallmarks of ES cells driven into diapause-like states by long-term inhibition of BET proteins, which regulate differentiation- and growth-promoting gene expression. Suppression of NRMAPK in diapause-like ES cells leads to differentiation and termination of the diapause-like state. Mechanistically, diapause-associated NRMAPK activation involves mTOR or BET inhibition-triggered release of the transcriptional repressor Capicua (CIC) from NRMAPK gene promoters. Our data highlight a key role for mTOR- and BET-controlled transcriptional regulation of MAP kinase activity via negative regulators in maintaining the pluripotent state of diapause ES cells and potentially other metabolically dormant stem or stem-like cells.

Indexed as

DiapauseEmbryonic Stem CellsGene Expression Regulation, DevelopmentalMitogen-Activated Protein KinasesPluripotent Stem CellsTranscription, GeneticAnimalsCell DifferentiationMiceTOR Serine-Threonine KinasesMitogen-Activated Protein KinasesmTOR protein, mouseTOR Serine-Threonine Kinasescell signalingdiapauseembryonic stem cellepigeneticsMAP kinase signalingmTOR signalingnascent transcriptional changestranscriptional regulation

Identifiers

PMID41381364
PMCPMC12951759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.